비교리스트

 카트 문의
시장보고서
상품코드
1364699

항균제 시장 : 제품 유형별, 투여 경로별, 유통별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 - 예측(2023-2030년)

Antimicrobials Market, By Product Type, By Route of Administration, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 281 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

항균제 시장 규모는 2022년 401억 2,080만 달러에 달했으며, 2023년부터 2030년까지 CAGR 6.31%로 확대

항균제 시장 - 시장 역학

세균 감염 증가는 항균제 시장의 성장을 가속할 것으로 예상됩니다.

항균제의 사용은 세균 감염 환자의 치료에 필수적입니다. 세균 감염의 부담에 관한 세계의 종합적 추계에 의하면, 2019년에는 세계에서 770만명이 세균성 질환에 의해 사망하고 있습니다. 이것은 세계 사망자 수의 8분의 1에 해당합니다. 또한 세균 감염은 허혈성 심장 질환에 이어 세계 2위의 사인으로 승격하고 있습니다. 세균 감염은 오랫동안 세계 건강 부담의 원인으로 과소 평가되어 완화 방법의 긴급한 증가가 필요합니다. 또한 세균 감염은 경미한 호흡기 감염에서 패혈증과 같은 치명적인 질병까지 다양합니다.

환자 수가 증가함에 따라 이러한 질병을 치료하고 통제하는 항균제에 대한 수요도 증가하고 있습니다. 세계보건기구(WHO)에 따르면 최근 과학적 발표에 따르면 2017년에는 세계 4,890만 명의 환자와 1,100만 명의 패혈증 관련 사망이 발생하여 세계 사망자 수의 거의 20%를 차지한 것으로 추정됩니다. 게다가, 생명공학 및 제약 분야의 혁신은 새로운 항균제 및 진단 도구의 개선을 위한 성장 기회를 제공할 수 있습니다. 그러나 저소득 국가에서 인프라의 부족은 시장 성장을 방해할 수 있습니다.

항균제 시장 - 세분화 분석 :

항균제 세계 시장은 제품 유형, 용도, 기술, 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 세 가지 범주로 나뉩니다. 방부제, 항생제, 항바이러스제, 항진균제, 항기생충제입니다. 항생제 분야가 시장을 독점하고 있는 이유는 인간에게 세균 감염이 널리 확산되어 있기 때문입니다. 항생제는 세균 감염의 예방과 치료에 사용되는 의약품입니다. 항균제 내성은 기생충(말라리아 등), 바이러스(HIV 등), 진균(칸디다 등)과 같은 다른 미생물에 의한 감염을 치료하는 약물에 대한 내성을 포함하는 더 넓은 용어입니다.

시장은 투여 경로에 따라 두 가지 범주로 나뉩니다. 경구 약물, 열대 약물, 비경구 약물 등. 항균제의 투여 경로는 이러한 약제가 어떻게 체내에 투여되는지를 좌우하는 중요한 역할을 담당하며, 그 결과, 효능이나 사용의 편리성이 좌우됩니다. 투여 경로는 사용하는 항균제, 치료할 감염, 환자의 상태 등의 요인에 의해 결정됩니다.

시장은 유통 경로에 따라 두 가지 범주로 나뉩니다. 클리닉, 병원 및 기타. 병원 부문이 시장을 독점하고 있습니다. 병원 약사는 전통적으로 제한 약의 사전 승인과 처방 의사에게 감사 및 피드백을 제공하는 등 의약품의 거버넌스에 대한 책임을 담당해 왔습니다. 또한 입원 환자의 다양한 수요에 대응하기 위해 폭넓은 항균제를 상비하고 있습니다.

항균제 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다. 북미는 헬스케어 인프라 투자 증가로 항균제 시장의 성장을 지배할 것으로 예상됩니다. 특히 미국은 1인당 헬스케어 지출로 항상 상위 순위를 차지하고 있습니다. 이 높은 수준의 지출은 의료 인프라에 대한 투자뿐만 아니라 의료 연구, 혁신적인 치료법 및 의약품의 진보에 대한 나라의 헌신을 나타냅니다. 미국의 의료비는 2021년에 2.7% 증가한 4조 3,000억 달러, 1인당 1만 2,914 달러에 달했습니다. 이 성장률은 2020년(10.3%)보다 상당히 낮습니다. 이 지출의 대폭적인 감속은 유행 관련 정부 지출 감소가 치료 지연과 2020년부터 수요 증가에 따라 회복된 의료품 및 서비스 이용 증가를 상쇄했기 때문으로 생각된다(미국 의사회). 유럽은 항균제 시장의 성장에서 두 번째로 큰 지역이며, 이는 공공기관과 민간기관에 의한 연구개발에 대한 투자가 증가하고 있기 때문입니다.

항균제 시장 - 경쟁 구도:

세계의 다제 내성 세균 병원체의 확산으로 인한 생명을 위협하는 감염을 치료하기 위한 새로운 항균제의 개발에 대한 현재의 투자 수준은, 특히 천연물 유래 및 합성 저분자 분야에서 계속 증가하는 항균제 수요와는 대조적입니다. 이 단계에서 제조업체는 새로운 항생제를 확인하고 개발하는 능력을 크게 향상시키기 위한 전략적 계획을 제공합니다. 이들은 학술, 산업, 정치의 이해관계자간의 격차를 메우고 차세대를 위한 트랜스레이셔널 파이프라인을 효율적으로 촉진하기 위해 학제간의 전문지식을 결집하는 것을 목적으로, 연구 및 자금 조달의 다양한 분야에서 가장 임박한 한계를 극복하기 위한 단기 및 장기 솔루션을 제안합니다. 또한 주요 제약 회사는 항균제 시장에서 중요한 역할을 하고 있습니다. 이들은 신규 항생제, 항진균제, 항바이러스제, 항기생충제의 발견과 제조를 위한 연구개발에 많은 투자를 하고 있습니다. 화이자, 머크, 존슨 엔드 존슨, 노바티스 등이 그 예입니다.

목차

제1장 항균제 시장 개요

  • 조사 범위
  • 시장 추정 연수

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 항균제의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 항균제 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀의 분석

제5장 항균제 시장 : COVID-19증의 영향 분석

  • 신형 코로나바이러스 감염증 이전의 영향 분석
  • 신형 코로나바이러스 감염증 후의 영향 분석

제6장 항균제 시장 상황

  • 항균제 시장 점유율 분석, 2022년
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 항균제 시장-제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 방부제
    • 항생제
    • 항바이러스제
    • 항진균제
    • 구충약

제8장 항균제 시장- 투여 경로별

  • 개요
    • 투여 경로별 부문 점유율 분석
    • 오랄
    • 화제
    • 비경구
    • 기타

제9장 항균제 시장- 유통별

  • 개요
    • 부문 점유율 분석(분포별)
    • 진료소
    • 병원
    • 기타

제10장 항균제 시장-지역별

  • 서문
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 항균제 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Abbott
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Merck &Co.Inc.,
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc,
    • Mylan NV
    • Aurobindo Pharma
    • Cipla Inc.
    • Sun Pharmaceutical Industries Ltd
    • Amneal Pharmaceuticals LLC
    • Alembic Pharmaceuticals Limited
    • Lupin, Novartis AG
    • Zydus Cadila
    • Bausch Health Companies Inc.
    • Johnson &Johnson Private Limited
    • Dr. Reddy's Laboratories Ltd.
    • AbbVie Inc

제12장 애널리스트의 전방위 전망

AJY 23.10.30

REPORT HIGHLIGHT

Antimicrobials Market size was valued at USD 40,120.8 Million in 2022, expanding at a CAGR of 6.31% from 2023 to 2030.

Antimicrobials are destroying or inhibiting the growth of microorganisms, especially pathogenic microorganisms. It is one of the most successful types of chemotherapy and has been used to protect the human population against infectious diseases. Many antimicrobials in general use are real antibiotics, having been identified from bacteria and fungi, but others are not. for example, The Environmental Protection Agency (EPA) in the United States regulates antimicrobial products as pesticides, while the Food and Drug Administration (FDA) in the United States regulates antimicrobial products as drugs/antiseptics. Antimicrobial products are used as pesticides on objects such as surfaces, toys, grocery carts, and hospital equipment. Antimicrobial products are used as antiseptics to treat or prevent diseases in humans, pets, and other living things.

Antimicrobials Market- Market Dynamics

An increase in the prevalence of bacterial infections is expected to drive Antimicrobials market growth.

The use of antibacterial agents is essential in the treatment of patients with bacterial infections. According to global comprehensive estimates of the burden of bacterial infections, 7.7 million deaths worldwide were due to bacterial illnesses in 2019. This equates to one-eighth of all global deaths. It also elevates bacterial infections to the world's second leading cause of death, trailing only ischemic heart disease. Bacterial infections have long been an underappreciated cause of global health burden, necessitating an urgent increase in mitigation methods. Also, bacterial infections can range from minor respiratory infections to potentially fatal illnesses such as sepsis.

As the number of persons afflicted grows, so does the demand for antimicrobial medications to treat and control these illnesses. According to the World Health Organization, a recent scientific publication estimated that in 2017 there were 48.9 million cases and 11 million sepsis-related deaths worldwide, which accounted for almost 20% of all global deaths. Furthermore, Innovations in the biotechnology and pharmaceutical sectors may provide a growing opportunity for novel antimicrobials and improved diagnostic tools, However, a lack of infrastructure in low-income countries may hamper the growth of the market.

Antimicrobials Market- Key Insights

  • As per the analysis shared by our research analyst, the global Antimicrobials market is estimated to grow annually at a CAGR of around 6.31% over the forecast period (2023-2030)
  • The antimicrobials market is expected to grow rapidly due to increased R&D efforts and well-established healthcare infrastructure.
  • Based on product type segmentation, Antibiotics was predicted to show maximum market share in the year 2022
  • Based on route of administration segmentation, Hospital sector was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Antimicrobials Market- Segmentation Analysis:

The Global Antimicrobials Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Antiseptics, Antibiotics, Antivirals, Antifungals and Antiparasitics. Antibiotics segment dominates the market, due to The widespread prevalence of bacterial infections in humans. Antibiotics are medicines used to prevent and treat bacterial infections. Antimicrobial resistance is a broader term, encompassing resistance to drugs to treat infections caused by other microbes as well, such as parasites (e.g. malaria), viruses (e.g. HIV) and fungi (e.g. Candida).

The market is divided into two categories based on Route of Administration: Oral, Tropical, Parenteral and others. Antimicrobial drug administration routes play an important role in influencing how these drugs are given to the body and, as a result, their effectiveness and convenience of usage. The route taken is determined by factors such as the antimicrobial used, the infection being treated, and the patient's state.

The market is divided into two categories based Distribution channel: Clinic, Hospital and others. Hospital sector dominate the market. Hospital pharmacists have traditionally assumed responsibilities in the governance of medications such as prior authorization for restricted drugs and provision of audit and feedback to prescribing physicians. Also, they have a wide range of antimicrobials on hand to meet the different demands of hospitalized patients.

Antimicrobials Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is projected to dominate the growth of the Antimicrobials market, due to Increasing investment in healthcare infrastructure. The United States, in particular, constantly ranks among the top countries in terms of healthcare expenditure per capita. This high level of spending shows not only investments in healthcare infrastructure, but also the country's dedication to medical research, innovative therapies, and pharmaceutical advancements. Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD 12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). This substantial deceleration in spending can be attributed to the decline in pandemic-related government expenditures offsetting increased utilization of medical goods and services that rebounded due to delayed care and pent-up demand from 2020, American Medical Association. Europe is the second largest region for the growth of the antimicrobials market, owing to rising in the investment for R&D by public and private organizations.

Antimicrobials Market- Competitive Landscape:

The current level of investment in the development of novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the ever-increasing demand for them, particularly in the fields of natural-product-derived and synthetic small molecules. In this phase, manufacturers provide a strategic plan to significantly improve their ability to identify and develop new antibiotics. They propose both short-term and long-term solutions to overcome the most pressing limitations in various sectors of research and funding, with the goal of bridging the gap between academic, industrial, and political stakeholders and uniting interdisciplinary expertise in order to efficiently fuel the translational pipeline for future generations. Furthermore, Large pharmaceutical corporations play an important role in the antimicrobials market. They invest substantially in research & development to discover and manufacture novel antibiotics, antifungals, antivirals, and Antiparasitics medications. Pfizer, Merck, Johnson & Johnson, and Novartis are some examples.

Recent Developments:

In October 5, 2023, Merck is Collaborating to Address Antimicrobial Resistance

Antibiotics have transformed health care and saved countless lives. But rising levels of antimicrobial resistance (AMR) can make current antibiotics less effective. There's no simple solution to the complex problem of AMR, but Merck are committed to investing its expertise and resources alongside their partners to get antibiotics to those who need them most. Lives are at risk, and the time to act is now.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIALS MARKET KEY PLAYERS

  • Abbott, AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Merck & Co.Inc.,
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc,
  • Mylan N.V.
  • Aurobindo Pharma
  • Cipla Inc.
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Lupin, Novartis AG
  • Zydus Cadila
  • Bausch Health Companies Inc.
  • Johnson & Johnson Private Limited
  • Dr. Reddy's Laboratories Ltd.
  • AbbVie Inc.,

GLOBAL ANTIMICROBIALS MARKET, BY PRODUCT TYPE

  • Antiseptics
  • Antibiotics
  • Antivirals
  • Antifungals
  • Antiparasitics

GLOBAL ANTIMICROBIALS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Topical
  • Parenteral
  • Others

GLOBAL ANTIMICROBIALS MARKET, BY DISTRIBUTION

  • Clinic
  • Hospital
  • Others

GLOBAL ANTIMICROBIALS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Antimicrobials Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobials Market Snippet by Product Type
    • 2.1.2. Antimicrobials Market Snippet by Route of Administration
    • 2.1.3. Antimicrobials Market Snippet by Distribution
    • 2.1.4. Antimicrobials Market Snippet by Country
    • 2.1.5. Antimicrobials Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobials Key Market Trends

  • 3.1. Antimicrobials Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobials Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobials Market Opportunities
  • 3.4. Antimicrobials Market Future Trends

4. Antimicrobials Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobials Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antimicrobials Market Landscape

  • 6.1. Antimicrobials Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobials Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Antiseptics
    • 7.1.3. Antibiotics
    • 7.1.4. Antivirals
    • 7.1.5. Antifungals
    • 7.1.6. Antiparasitics

8. Antimicrobials Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Topical
    • 8.1.4. Parenteral
    • 8.1.5. Others

9. Antimicrobials Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
    • 9.1.2. Clinic
    • 9.1.3. Hospital
    • 9.1.4. Others

10. Antimicrobials Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Antimicrobials Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Antimicrobials Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Antimicrobials Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Antimicrobials Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Antimicrobials Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antimicrobials Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. AstraZeneca
    • 11.2.3. Bristol-Myers Squibb Company
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Merck & Co.Inc.,
    • 11.2.6. F. Hoffmann-La Roche Ltd
    • 11.2.7. GlaxoSmithKline plc,
    • 11.2.8. Mylan N.V.
    • 11.2.9. Aurobindo Pharma
    • 11.2.10. Cipla Inc.
    • 11.2.11. Sun Pharmaceutical Industries Ltd
    • 11.2.12. Amneal Pharmaceuticals LLC
    • 11.2.13. Alembic Pharmaceuticals Limited
    • 11.2.14. Lupin, Novartis AG
    • 11.2.15. Zydus Cadila
    • 11.2.16. Bausch Health Companies Inc.
    • 11.2.17. Johnson & Johnson Private Limited
    • 11.2.18. Dr. Reddy's Laboratories Ltd.
    • 11.2.19. AbbVie Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제